Blood Coagulation Factor XIV

Blood Coagulation Factor XIV Uses, Dosage, Side Effects, Food Interaction and all others data.

Blood Coagulation Factor XIV is an endogenously occurring plasma protein that plays a key role within the coagulation cascade. Blood Coagulation Factor XIV is a zymogen, or enzyme precursor, of a vitamin K-dependent anticoagulant glycoprotein (serine protease) that is synthesized in the liver. It is converted by the thrombin/thrombomodulin-complex on the endothelial cell surface to Activated Blood Coagulation Factor XIV (APC). Once in its activated form, APC functions as a serine protease with potent anticoagulant effects, especially in the presence of its cofactor protein S. APC exerts its effect by inactivating essential components of the coagulation cascade (specifically factors V and VIII), which leads to a decrease in thrombin formation, and therefore a reduction in clot formation.

The Blood Coagulation Factor XIV pathway provides a natural mechanism for control of the coagulation system and prevention of excessive procoagulant responses to activating stimuli. A lack of protein C in the body would lead to unchecked coagulation activation, resulting in thrombin generation and intravascular clot formation.

Blood Coagulation Factor XIV is available in concentrated form as the product Ceprotin, which is indicated for use in pediatric and adult patients with severe congenital protein C deficiency for the prevention and treatment of venous thrombosis and purpura fulminans.

Blood Coagulation Factor XIV
Uses
Dosage
Side Effect
Precautions
Interactions
Uses during Pregnancy
Uses during Breastfeeding
Accute Overdose
Food Interaction
Half Life
Volume of Distribution
Clearance
Interaction With other Medicine
Contradiction
Storage

Trade Name	Blood Coagulation Factor XIV
Generic	Protein C
Protein C Other Names	autoprothrombin IIA, blood coagulation factor XIV, Human protein C, Protein C (coagulation inhibitor), Protein C concentrate, Protein C concentrate (human), Protein C concentrate human, Protein C human
Type
Groups	Approved
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

Blood Coagulation Factor XIV is a medication used to treat protein C deficiency leading to purpura fulminans or coumarin-induced skin necrosis.

Blood Coagulation Factor XIV concentrate is indicated for pediatric and adult patients with severe congenital protein C deficiency for the prevention and treatment of venous thrombosis and purpura fulminans. It is also found as a component of some prothrombin complex concentrate (i.e. Factor IX Complex (Human)) formulations, such as Kcentra.

Blood Coagulation Factor XIV is also used to associated treatment for these conditions: Purpura Fulminans, Thrombosis, Venous

How Blood Coagulation Factor XIV works

Blood Coagulation Factor XIV is an endogenously occurring plasma protein that plays a key role within the coagulation cascade. Also known as blood coagulation factor XIV, Blood Coagulation Factor XIV is a zymogen, or enzyme precursor, of a vitamin K-dependent anticoagulant glycoprotein (serine protease) that is synthesized in the liver. It is converted by the thrombin/thrombomodulin-complex on the endothelial cell surface to Activated Blood Coagulation Factor XIV (APC). Once in its activated form, APC functions as a serine protease with potent anticoagulant effects, especially in the presence of its cofactor protein S. APC exerts its effect by inactivating essential components of the coagulation cascade (specifically factors V and VIII), which leads to a decrease in thrombin formation, and therefore a reduction in clot formation.

Food Interaction

Avoid herbs and supplements with anticoagulant/antiplatelet activity. Examples include garlic, ginger, bilberry, danshen, piracetam, and ginkgo biloba.